Aurora Cannabis (TSX:ACB): Is the Stock Price Pullback Complete?

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) dropped nearly 50% from the recent high, but it’s starting to claw back the losses. Is it time to buy this pot stock?

| More on:

Aurora Cannabis (TSX:ACB)(NYSE:ACB) took a big hit when investors sold off most marijuana stocks in recent weeks.

The past few sessions, however, have been more favourable, and investors who are sitting on the sidelines are wondering if this is the right time to step in and buy Aurora Cannabis stock for their pot stock portfolios.

Let’s take a look at one of Canada’s largest players in the cannabis sector to see if it deserves to be on your buy list.


Aurora Cannabis has taken an aggressive approach to consolidating the Canadian medical marijuana industry. The company bought CanniMed for $1.1 billion in January in a deal that added important production capacity as well as research and development expertise. In July, Aurora Cannabis closed its $2.5 billion takeover of MedReleaf. The acquisition brought a large client list of medical marijuana patients and further expanded production capacity as well as the portfolio of recognized brands.

With a current market capitalization of more than $9 billion, Aurora Cannabis has the size to make additional moves in its bid to compete with larger peers Canopy Growth and Tilray as the Canadian and global markets expand.


A number of smaller players might be attractive, but HEXO could be the one that Aurora Cannabis targets. HEXO has a dominant position in Quebec and is already working to enter the cannabis-infused drinks market through its partnership with Molson Coors Canada.

Rumours have emerged that Aurora Cannabis might be in talks with potential beverage partners, but acquiring HEXO could be a way to get instant access to the segment. HEXO has a market capitalization of about $1.3 billion.

A larger deal would be a takeover of Aphria. In that case, Aurora would become a giant in the medical cannabis space in both Canada and abroad. Aphria’s current market capitalization is about $4 billion.


Despite the plunge in the stock price from $15 per share on October 15 to the October 29th closing price of $7.70, the stock still looks expensive. Current annualized revenue is less than $80 million.

The entire sector is in the same boat, so investors just have to be careful when deciding how much exposure they want to have to the marijuana industry.

Should you buy?

At the time of writing, Aurora Cannabis has a stock price of $10 per share. Investors who had the courage to step in at $8 are already sitting on some nice gains, and more upside could certainly be on the way. As one of the larger players, there isn’t much chance of getting a big takeover premium. That said, any news of a major investment from a beverage giant could send the stock back toward the recent highs.

Aurora Cannabis will likely be one of the few companies that survives the consolidation process to dominate the global medical marijuana market. If you like the industry’s long-term prospects and have the stomach for additional volatility, the stock might be attractive today.

Otherwise, there are additional ways to play the emerging marijuana market.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Investing

energy oil gas
Energy Stocks

Is Suncor (TSX:SU) Stock Still a Buy at $50?

Suncor is finally catching a tailwind. Is it too late to buy the stock?

Read more »

Portrait of woman having fun in the street.
Stocks for Beginners

New Investors: 3 Dividend Stocks to Buy Soon

Are there too many stocks to choose from? New investors can start their research in these solid dividend stocks!

Read more »

online shopping
Tech Stocks

Shopify (TSX:SHOP): A Top TSX Growth Stock for 2022’s 2nd Half?

Shopify (TSX:SHOP)(NYSE:SHOP) stock is an e-commerce darling that's suffered a massive fall from the very top of the Canadian market.

Read more »

canadian energy oil
Energy Stocks

Oil Stocks Are Still Shockingly Cheap

Oil stocks like Suncor Energy (TSX:SU)(NYSE:SU) are still incredibly cheap.

Read more »

Canadian energy stocks are rising with oil prices
Dividend Stocks

2 Canadian Energy Stocks With Ridiculously Fast-Growing Dividends

Canadian energy stocks are gushing cash and there's plenty left for shareholders. Here are two stocks for ridiculously fast-growing dividends

Read more »

Target. Stand out from the crowd
Tech Stocks

Why Constellation Stock Belongs on Everyone’s Buy List

Constellation (TSX:CSU) stock provides a valuable investment for those seeking strong growth for years to come, even in a weak…

Read more »

cryptocurrency, crypto, blockchain

2 Crypto Stocks to Buy Despite Bitcoin’s (CRYPTO:BTC) Slump

Two TSX crypto stocks are interesting buys, despite the slump of cryptocurrencies and the support of a top U.S. investment…

Read more »

retirees and finances
Dividend Stocks

Retirees: 2 Top TSX Dividend Stocks to Buy for TFSA Passive Income

These industry leaders pay attractive dividends for a portfolio focused on passive income.

Read more »